Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer |
Wang, Bu-Hai
(Department of Oncology of Subei People's Hospital, Yangzhou University)
Cao, Wen-Miao (Department of Oncology of Subei People's Hospital, Yangzhou University) Yu, Jie (Department of Oncology of Subei People's Hospital, Yangzhou University) Wang, Xiao-Lei (Department of Oncology of Subei People's Hospital, Yangzhou University) |
1 | Banu E, Banu A, Fodor A, et al (2007). Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer. Drugs Aging, 24, 865. DOI |
2 | Bria E, Milella M, Gelibter A, et al (2007). Gemcitabine based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials. Cancer, 110, 525. DOI |
3 | Brunner TB, Scott-Brown M (2010). The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol, 5, 64. DOI |
4 | Burris HA, Moore MJ, Andersen J, et al (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15, 2403-13. DOI |
5 | Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17. DOI |
6 | Hunter KU, Feng FY, Griffith KA, et al (2011). Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys, 83, 921-6. |
7 | Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. DOI ScienceOn |
8 | Li D, Xie K, Wolff R, et al (2010). Pancreatic cancer. Lancet, 1363, 1049-57. |
9 | Loehrer PJ Sr, Feng Y, Cardenes H, et al (2011). Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol, 29, 4105-12. DOI ScienceOn |
10 | Ni QX, Fu DL (2006). Combined therapy based on tumor biology characteristic for advanced pancretic cancer. Theory Pract Surg, 11, 471-7. |
11 | Sener SF, Fremgen A (1999). Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg, 189, 1-7. DOI ScienceOn |
12 | Sultana A, Smith CT, Cunningham D, et al (2007). Met-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol, 25, 2607. DOI |
13 | Zhu CP, Shi J, Chen YX, et al (2011). Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis. Radiother Oncol, 99, 108-13. DOI |